Instil Bio’s stock surged over 25% on Tuesday to levels last seen in early December after Jefferies upgraded the shares to ...

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...

Jefferies analyst Brent Thill upgraded Procore (PCOR) to Buy from Hold with a price target of $100, up from $80. The firm expects a favorable ...

Topgolf Callaway stock rose Thursday after Jefferies analysts raised their rating on shares of the golf equipment ...

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...

Jefferies analyst Sheila Kahyaoglu lowered the firm’s price target on Leidos (LDOS) to $160 from $175 and keeps a Hold rating on the shares.

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...

Rural demand shows promise, but urban weakness and muted volumes continue to weigh on consumer staples. As Q3 results loom, ...